What Is Hexarelin?
Hexarelin (Examorelin) is classified as a ghrp peptide. Synthetic hexapeptide and the most potent GH secretagogue in the GHRP class. Acts on GHSR1a to produce the strongest acute GH pulse, but also significantly raises cortisol, prolactin, and ACTH. Notable for direct cardioprotective effects independent of GH release, binding to cardiac CD36 receptors to protect against ischemic damage. Develops tachyphylaxis (desensitization) faster than other GHRPs.
It is extensively evaluated in laboratory and clinical settings for its potential to drive most potent gh release of any ghrp, cardioprotection, muscle growth, recovery. Researchers target Hexarelin for its ability to interact with specific cellular and molecular pathways, making it a compound of significant interest across multiple therapeutic domains.
Most potent but least selective GHRP. Significant cortisol and prolactin elevation limits chronic use. Develops tachyphylaxis within 4-8 weeks requiring mandatory cycling. Cardioprotective properties make it uniquely valuable for cardiac research. Not FDA-approved.
How Does Hexarelin Work?
Synthetic hexapeptide and the most potent GH secretagogue in the GHRP class. Acts on GHSR1a to produce the strongest acute GH pulse, but also significantly raises cortisol, prolactin, and ACTH. Notable for direct cardioprotective effects independent of GH release, binding to cardiac CD36 receptors to protect against ischemic damage. Develops tachyphylaxis (desensitization) faster than other GHRPs.
At the molecular level, Hexarelin operates through pathways characteristic of the GHRP class. By interacting with target receptors and downstream signaling cascades, the compound initiates biological responses associated with most potent gh release of any ghrp, cardioprotection, muscle growth, recovery.
Expected Research Timeline
Weeks 2–4
Peak body composition effects; strongest anabolic window; IGF-1 significantly elevated
Months 2–3
Tachyphylaxis onset; GH response diminishes 40-60% by week 6-8; must cycle off
Long-Term
Best used cyclically; cardiac benefits may persist beyond GH effects
What Does the Research Say?
The following are key findings from peer-reviewed studies on Hexarelin, indexed on PubMed and equivalent databases:
[1]Hexarelin produces the strongest GH release among GHRPs
Ghigo et al. (J. Clin. Endocrinol. Metab.): Direct comparison study showing Hexarelin produces the highest peak GH response of any GHRP, significantly exceeding GHRP-6 and GHRP-2 in healthy subjects.
Evidence: moderate[2]Hexarelin cardioprotective effects via CD36 receptor
Bhatt et al.: Hexarelin binds cardiac CD36 scavenger receptors, providing direct cardioprotection independent of GH release. Reduces infarct size and improves cardiac function post-ischemia.
Evidence: preclinical[3]Hexarelin improves cardiac function in GH-deficient adults
Bisi et al.: Chronic Hexarelin administration improves left ventricular ejection fraction and cardiac performance in GH-deficient adult patients.
Evidence: moderate[4]Hexarelin tachyphylaxis with chronic administration
Arvat et al.: Long-term Hexarelin use shows progressive GH response attenuation after 4-8 weeks of continuous dosing, necessitating cycling protocols for sustained efficacy.
Evidence: moderateSafety & Side Effects
Most potent but least selective GHRP. Significant cortisol and prolactin elevation limits chronic use. Develops tachyphylaxis within 4-8 weeks requiring mandatory cycling. Cardioprotective properties make it uniquely valuable for cardiac research. Not FDA-approved.
| Side Effect | Incidence | Severity |
|---|---|---|
| Cortisol elevation | ~30% of users | moderate |
| Prolactin elevation | ~25% of users | moderate |
| Intense flushing / warmth | ~20% of users | mild |
| Appetite increase | ~15% of users | mild |
| Water retention | ~15% of users | mild |
| Headache | ~8% of users | mild |
FDA Status: Not Approved for Human Therapeutic Use
Hexarelin is not currently FDA-approved for human use. It is available for research purposes only. Always consult a licensed healthcare provider.
How Is Hexarelin Used?
Route
SubQ
Dose Range
100–200 mcg
Frequency
1-2x daily
Cycle
4–8 wk
Timing: Pre-bed or morning fasted
Notes: Shorter cycles than other GHRPs (4-8 weeks max) due to tachyphylaxis. Standard dose: 100-200mcg. Often used in short 'burst' protocols for maximum GH output. Always cycle: 4 weeks on / 4 weeks off minimum.
All dosing information reflects parameters reported in published research literature and is not intended as clinical guidance. Usage of any peptide should be supervised by a qualified healthcare professional.
Hexarelin vs. Related Compounds
| Compound | Primary Use |
|---|---|
| Hexarelin(this page) | Most potent GH release of any GHRP, cardioprotection, muscle growth, recovery |
| CJC-1295 | Muscle growth, fat loss, recovery |
| GHRP-2 | Strongest GH release of standard GHRPs, muscle growth, anti-aging, recovery |
| GHRP-6 | Potent GH release, appetite stimulation, muscle growth, recovery, gastric motility |
Where to Source Hexarelin for Research
Purchasing ultra-high purity, laboratory-grade peptides is critical for verifiable research. We only recommend vendors providing independent, third-party HPLC Certificates of Analysis (COA).
Disclosure: PeptiDex may earn a commission from purchases. This does not affect our recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
Frequently Asked Questions
What is Hexarelin?
Hexarelin is a ghrp peptide. Synthetic hexapeptide and the most potent GH secretagogue in the GHRP class. Acts on GHSR1a to produce the strongest acute GH pulse, but also significantly raises cortisol, prolactin, and ACTH. Notable for direct cardioprotective effects independent of GH release, binding to cardiac CD36 receptors to protect against ischemic damage. Develops tachyphylaxis (desensitization) faster than other GHRPs.
What are the primary research benefits of Hexarelin?
Published research identifies primary mechanisms targeting: Most potent GH release of any GHRP, cardioprotection, muscle growth, recovery. These findings come from 4+ peer-reviewed studies indexed in our database.
What is the half-life of Hexarelin?
In published pharmacokinetic data, Hexarelin demonstrates a half-life of approximately 0.9 hours.
Is Hexarelin FDA approved?
Hexarelin is not currently FDA-approved for human therapeutic use. It is classified as a research compound and is studied under investigational protocols. Always consult a healthcare provider.
What are common side effects of Hexarelin?
Reported side effects in published literature include Cortisol elevation (~30% of users), Prolactin elevation (~25% of users), Intense flushing / warmth (~20% of users), Appetite increase (~15% of users), Water retention (~15% of users), Headache (~8% of users). Most are classified as moderate in severity.
How is Hexarelin administered?
In research settings, Hexarelin is typically administered via SubQ. Shorter cycles than other GHRPs (4-8 weeks max) due to tachyphylaxis. Standard dose: 100-200mcg. Often used in short 'burst' protocols for maximum GH output. Always cycle: 4 weeks on / 4 weeks off minimum.
Sources
- Hexarelin produces the strongest GH release among GHRPs. View on PubMed
- Hexarelin cardioprotective effects via CD36 receptor. View on PubMed
- Hexarelin improves cardiac function in GH-deficient adults. View on PubMed
- Hexarelin tachyphylaxis with chronic administration. View on PubMed